| |
| Magyar Immunológiai Társaság |
|
| Cutaneous Lymphomas 2013 |
 Rendezvény kezdete: 2013.02.06. | Rendezvény vége: 2013.02.09. |
| Szervező: Annette Gleich |
| Munkahely neve: MCI Deutschland GmbH | MCI – Berlin Office |
| Címe: Markgrafenstrasse 56 | 10117 Berlin | Germany |
| Tel: +49 (0)30 20 45 90 |
| Fax: +49 (0)30 20 45 950 |
| E-mail: lymphomas2013@mci-group.com |
| Helyszín: Germany / Németország, Berlin, |
| A rendezvény Web oldala: http://www.cutaneouslymphomas2013.com/ |
2nd WCCL/6th ISBICL 2013
World Congress of Cutaneous Lymphomas (WCCL) and International Symposium on the Biology and Immunology of Cutaneous Lymphoma (ISBICL)
Dear colleagues,
Following the immensely successful 1st World Congress of Cutaneous Lymphomas (WCCL) in Chicago with its clinical emphasis and the 5th International Symposium on the Biology and Immunology of Cutaneous Lymphoma (ISBICL) with its focus on basic and translational research, we are most delighted to invite you to join us at the 2nd WCCL/6th ISBICL 2013 in Berlin. This unique meeting will review both the latest research and development relating to cutaneous lymphomas and the clinical practice including new therapies and clinical trials. The congress is supported by the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium and the EORTC Cutaneous Lymphoma Task Force.
In addition to a rewarding congress program, the visit to Berlin will bring you right into touch with the profound political changes of recent years and into one of the most vibrant cultural centers of the world with numerous concerts, operas, theaters, cabarets, museums, exhibitions, fairs and off-stage events. All who have visited the city before will be amazed of the rapid developments and will find ever new paths to explore.
We look forward to welcoming you in Berlin for a certainly most exciting congress and a rich personal experience.
Yours cordially
The International Program Committee
The Local Organizing Committee
Abstract submission deadline extended until December 14, 2012
|
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| Cutaneous Lymphomas 2013 |
| Rendezvény kezdete: 2013.02.06. | Rendezvény vége: 2013.02.09. |
| Szervező: Annette Gleich |
| Munkahely neve: MCI Deutschland GmbH | MCI – Berlin Office |
| Címe: Markgrafenstrasse 56 | 10117 Berlin | Germany |
| Tel: +49 (0)30 20 45 90 |
| Fax: +49 (0)30 20 45 950 |
| E-mail: lymphomas2013@mci-group.com |
| Helyszín: Germany / Németország, Berlin, |
| A rendezvény Web oldala: http://www.cutaneouslymphomas2013.com/ |
2nd WCCL/6th ISBICL 2013
World Congress of Cutaneous Lymphomas (WCCL) and International Symposium on the Biology and Immunology of Cutaneous Lymphoma (ISBICL)
Dear colleagues,
Following the immensely successful 1st World Congress of Cutaneous Lymphomas (WCCL) in Chicago with its clinical emphasis and the 5th International Symposium on the Biology and Immunology of Cutaneous Lymphoma (ISBICL) with its focus on basic and translational research, we are most delighted to invite you to join us at the 2nd WCCL/6th ISBICL 2013 in Berlin. This unique meeting will review both the latest research and development relating to cutaneous lymphomas and the clinical practice including new therapies and clinical trials. The congress is supported by the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium and the EORTC Cutaneous Lymphoma Task Force.
In addition to a rewarding congress program, the visit to Berlin will bring you right into touch with the profound political changes of recent years and into one of the most vibrant cultural centers of the world with numerous concerts, operas, theaters, cabarets, museums, exhibitions, fairs and off-stage events. All who have visited the city before will be amazed of the rapid developments and will find ever new paths to explore.
We look forward to welcoming you in Berlin for a certainly most exciting congress and a rich personal experience.
Yours cordially
The International Program Committee
The Local Organizing Committee
Abstract submission deadline extended until December 14, 2012
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| Cutaneous Lymphomas 2013 |
| Rendezvény kezdete: 2013.02.06. | Rendezvény vége: 2013.02.09. |
| Szervező: Annette Gleich |
| Munkahely neve: MCI Deutschland GmbH | MCI – Berlin Office |
| Címe: Markgrafenstrasse 56 | 10117 Berlin | Germany |
| Tel: +49 (0)30 20 45 90 |
| Fax: +49 (0)30 20 45 950 |
| E-mail: lymphomas2013@mci-group.com |
| Helyszín: Germany / Németország, Berlin, |
| A rendezvény Web oldala: http://www.cutaneouslymphomas2013.com/ |
2nd WCCL/6th ISBICL 2013
World Congress of Cutaneous Lymphomas (WCCL) and International Symposium on the Biology and Immunology of Cutaneous Lymphoma (ISBICL)
Dear colleagues,
Following the immensely successful 1st World Congress of Cutaneous Lymphomas (WCCL) in Chicago with its clinical emphasis and the 5th International Symposium on the Biology and Immunology of Cutaneous Lymphoma (ISBICL) with its focus on basic and translational research, we are most delighted to invite you to join us at the 2nd WCCL/6th ISBICL 2013 in Berlin. This unique meeting will review both the latest research and development relating to cutaneous lymphomas and the clinical practice including new therapies and clinical trials. The congress is supported by the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium and the EORTC Cutaneous Lymphoma Task Force.
In addition to a rewarding congress program, the visit to Berlin will bring you right into touch with the profound political changes of recent years and into one of the most vibrant cultural centers of the world with numerous concerts, operas, theaters, cabarets, museums, exhibitions, fairs and off-stage events. All who have visited the city before will be amazed of the rapid developments and will find ever new paths to explore.
We look forward to welcoming you in Berlin for a certainly most exciting congress and a rich personal experience.
Yours cordially
The International Program Committee
The Local Organizing Committee
Abstract submission deadline extended until December 14, 2012
|
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| Upgrading Course on Aesthetic Medicine |
| Rendezvény kezdete: 2012.11.29. | Rendezvény vége: 2012.11.30. |
| Szervező: Dror Alon |
| E-mail: dror@omni-present.co.il |
| Helyszín: Izrael, Tel Aviv, |
Dr. Monica Elman, a well-known dermatologist, laser and IPL specialist in Israel will conduct a unique international Aesthetic Course that will be held in Israel on November 29-30, 2012.
The course targets physicians interested in enhancing their practical skills in Aesthetic Medicine.
During the course participants will be practicing innovative Aesthetic procedures with "hands on" human cadavers, and, in part, on live candidates.
The course will be conducted by Dr. M. Elman together with international specialists in the field.
Dr. M. Elman is the coauthor of the Dermatology book "Aesthetic Applications of Intense Pulsed Light", studied in USA medical schools. Her Aesthetic state of the art offices were chosen by the FDA regulatory offices to serve as a control |
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| Upgrading Course on Aesthetic Medicine |
| Rendezvény kezdete: 2012.11.29. | Rendezvény vége: 2012.11.30. |
| Szervező: Dror Alon |
| E-mail: dror@omni-present.co.il |
| Helyszín: Izrael, Tel Aviv, |
Dr. Monica Elman, a well-known dermatologist, laser and IPL specialist in Israel will conduct a unique international Aesthetic Course that will be held in Israel on November 29-30, 2012.
The course targets physicians interested in enhancing their practical skills in Aesthetic Medicine.
During the course participants will be practicing innovative Aesthetic procedures with "hands on" human cadavers, and, in part, on live candidates.
The course will be conducted by Dr. M. Elman together with international specialists in the field.
Dr. M. Elman is the coauthor of the Dermatology book "Aesthetic Applications of Intense Pulsed Light", studied in USA medical schools. Her Aesthetic state of the art offices were chosen by the FDA regulatory offices to serve as a control |
|
|
|
